Recombinant Anti-albumin x Anti-IL-6R Bispecific Antibody (CrossMab)  (CROSSAB-H192)

Recombinant Anti-albumin x Anti-IL-6R Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can act as PK-modulated receptor antagonist. It is designed for the research of Lupus, rheumatoid arthritis therapy.

Datasheet